Keynote Speaker

Dr. Peter Schultz, PhD

We are honored to present Dr. Peter Schultz as the Plenary Speaker for WIPOS 2023. Dr. Schultz serves as the president and CEO of Scripps Research and is recognized globally for his groundbreaking contributions to chemistry and biotechnology. His work includes the expansion of the genetic code in living organisms, the discovery of catalytic antibodies, and pioneering molecular diversity technologies in medical and chemical research.

Among his many accolades, Dr. Schultz has received the Wolf Prize in Chemistry, the Solvay Prize, and is a member of the National Academy of Sciences. He is also the founder of several influential biotech companies and continues to lead Calibr, advancing medicinal discoveries.


View Speakers
Dr. Peter Schultz



Oct. 8
2024

250
Tickets

11
Speakers





Speakers


Peter G. Schultz

Peter G. Schultz

Ph.D., Chemistry

The Scripps Research Institute

Peter G. Schultz is an American chemist and a key figure in synthetic innovation. CEO and Professor at The Scripps Research Institute.


Visit Peter's Lab
Katherine Y. King

Katherine Y. King

M.D., Ph.D., School of Medicine

Baylor College of Medicine

Professor, Pediatric-Infectious Disease. Focus on Hematopoietic Stem Cell Responses to Infection.


Email: kyk@bcm.edu

More about Nimmi
Hua Yu

Hua Yu

Ph.D., Tumor Immunotherapy

City of Hope

Leading research on the role of Stat3 in cancer biology and tumor immune evasion.


Email: HYu@coh.org

Hua Yu's Research
Sam Peng

Sam Peng

Ph.D., Chemistry and Biology

Broad Institute of MIT and Harvard

Expert in developing optical imaging techniques for studying molecular dynamics in diseases.


Email: sampeng@broadinstitute.org

Sam's Bio at Broad Institute
Matthew Blake Greenblatt

Matthew Blake Greenblatt

M.D. Ph.D., Pathology and Laboratory Medicine

Weill Cornell Medicine

Associate Professor at Weill Cornell Medicine, specializing in pathology and laboratory medicine.


Email: mag3003@med.cornell.edu

Phone: (212) 746-1602

Matthew's Profile
Ekrem Emrah Er

Ekrem Emrah Er

Ph.D., Physiology and Biophysics

University of Illinois Chicago

Assistant Professor in the Department of Physiology and Biophysics at UIC, focusing on cellular dynamics.


Email: eer@uic.edu

Ekrem's Academic Profile
Jamie B. Spangler

Jamie B. Spangler

Ph.D., Biomedical Engineering

Johns Hopkins University

Focuses on engineering protein therapeutics and vaccines at Johns Hopkins. William R. Brody Faculty Scholar.


Email: jamie.spangler@jhu.edu

Office: (443) 287-1708; Cell: (847) 858-1743

Learn more about Jamie
Lingyin Li

Lingyin Li

Ph.D., Biochemistry

Stanford University

Associate Professor at Stanford, exploring biochemical pathways and molecular mechanisms.


Email: lingyinl@stanford.edu

Lingyin's Faculty Page
Igor Bado

Igor Bado

Ph.D., Oncological Sciences

Icahn School of Medicine at Mount Sinai

Assistant Professor focused on oncological sciences, exploring cancer biology and therapy.


Email: igor.bado@mssm.edu

Office: 212-241-0733

Visit Igor's Lab
Igor Bado

Omid Veiseh

Ph.D., Bioengineering

Rice University

Professor of Bioengineering, CPRIT Scholar in Cancer Research.


Email: omid.veiseh@rice.edu

Office: 713-348-3082

Visit Veiseh's Lab
Igor Bado

Xi Chen

Ph.D., Immunology

MD Anderson Cancer Center

Cullen Duncan McAshan Endowed Chair in Cancer Research.


Email: xi.chen@bcm.edu

Visit Chen's Lab

Schedule


Morning

8:00

Opening remarks, Pavan Reddy, PhD

8:10

Targeting Cellular Biophysics within the Tumor Microenvironment, Ekrem Emrah Er, PhD

8:50

Bone biology; skeletal stem cells; signal transduction, Matthew Blake Greenblatt, MD PhD

9:30

Deliver Single and Bispecific Cas9/guide RNA to Perturb Genes in Vitro and in Vivo Efficiently and Specifically, Hua Yu, PhD

10:10

Rice/BCM Rising Star in Translational Cancer Research Award: Targeting receptor conversion in breast cancer metastasis: lessons learned from the osteogenic niche, Igor L. Bado, PhD

11:10

Engineering photostable probes to investigate molecular mechanisms at the single-molecule level , Sam Peng, PhD

11:50

Engineering cytokines to advance cancer immunotherapy , Jamie B. Spangler , PhD

12:30

Hybrid Bioelectronics for Feed-back Regulated Cancer Immunotherapy, Omid Veiseh, PhD

Afternoon

2:10

Chemical biology to uncover biochemical mechanisms in innate immunity and, in parallel, develop therapeutic hypotheses and lead compounds, Lingyin Li, PhD

2:50

Interferons: Friend or Foe, Katherine King, PhD

3:30

Stressing Out Therapy-Resistant Cancers, Xi chen, PhD

4:30

Keynote Talk: Bridging Basic Research and the Clinic in the Nonprofit World, Peter G. Schultz, PhD

Registration






Event Partners





v



FAQ


Contact Us